CXCR4 and neoplasm: We targeted CXCR4, achemokine receptor involved in tumor growth and metastasis. The CXCR4-targeting LIPTAC was built using aCXCR4 antagonizing nanobody (Nb) on onearm and the LDLR 142F1 Fab on the other arm of the Fc.